Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Bristol Myers Squibb News
CELG.R
BRISTOL MYERS SQUIBB CO
CELG.R
BRISTOL MYERS SQUIBB CO
Top stories
Bristol Myers Squibb ($BMY) Ends $650M ADC Deal with Eisai ($ESALY) Amid Portfolio Prioritization
Authors
12
18 hours
Economics
Bio
Business
FDA Approves Bristol Myers Squibb's KRAS G12C Combination Therapy for Colorectal Cancer
Authors
7
10 days
Bio
Science
Articles
Latest stories
Bristol Myers Squibb ($BMY) Ends $650M ADC Deal with Eisai ($ESALY) Amid Portfolio Prioritization
Authors
12
18 hours
Economics
Bio
Business
FDA Approves Bristol Myers Squibb's KRAS G12C Combination Therapy for Colorectal Cancer
Authors
7
10 days
Bio
Science
FDA Approves Bristol Myers' Breyanzi (Liso-Cel) for Relapsed Mantle Cell Lymphoma, Third Approval This Year
Authors
6
1 month
Bio
Science
Cytokinetics' Heart Drug Shows Promise, CEO Robert Blum Addresses Acquisition Speculation
Authors
5
2 months
Bio
Science
FDA Grants Accelerated Approval for Bristol Myers' Breyanzi for Follicular Lymphoma
Authors
7
2 months
Bio
Science
Cytokinetics' aficamten drug poised to challenge Bristol Myers Squibb's heart treatment with similar efficacy and safety, gearing up for potential launch
Authors
11
2 months
Bio
Science
Cytokinetics to Pitch Aficamten, Competing with BMS' $13.1B Camzyos
Authors
9
2 months
Bio
Science
Federal Judges Rule Against J&J, BMS in Medicare, Inflation Reduction Act Challenges
Authors
7
2 months
Bio
Crime
Science
Judge Upholds IRA Drug Price Talks for J&J, Bristol Myers' Blood Clot Drugs
Authors
12
2 months
Bio
Crime
Science
Court dismisses Bristol Myers Squibb, J&J challenges to Medicare drug price negotiations, rejecting unconstitutionality claims
Authors
4
2 months
Economics
Crime
Law
Mixed Q1: Bristol Myers Cuts Jobs, AstraZeneca and Merck Excel, Energy Struggles, Gilead Loss
Authors
38
2 months
Economics
Crime
Business
L3Harris to Cut 5% of Workforce, Bristol Myers to Slash 2,200 Jobs in Cost-Cutting Measures
Authors
23
2 months
Bio
Science
Bristol Myers Cuts Earnings Forecast, Launches $1.5B Cost Cuts, Cuts 2,200 Jobs; Stock Slips Amid Sluggish Sales
Authors
5
2 months
Economics
Business
Bristol Myers Cuts $1.5B Costs, 2,200 Jobs, Beats Revenue Estimates
Authors
10
2 months
Bio
Science
L3Harris, Bristol Myers, and Roche Announce Job Cuts and Strategic Shifts
Authors
27
2 months
Bio
Crime
Science
Bristol Myers Squibb, Sanofi to Pay $380M, $100M in Cancer Lawsuit Settlements
Authors
7
2 months
Economics
Business
Bristol Myers, Cellares Ink $380M Deal to Boost CAR-T Therapy Production
Authors
7
2 months
Bio
Science
Seaport Therapeutics Launches with Oversubscribed $100M Series A, Aims to Revolutionize Neuropsychiatric Treatment
Authors
17
3 months
Bio
Crime
Science
Bristol Myers' Zeposia Fails Main Goal in Crohn's Disease Study Phase 3 Trial
Authors
6
3 months
Bio
Science
Gilead Pays Xilio $43.5M in Deal Worth Three Times Market Cap for IL-12 Program
Authors
5
3 months
Bio
Science
Bristol Myers Opdivo-Yervoy Combo Succeeds in CheckMate-9DW Study for Liver Cancer
Authors
11
3 months
Bio
Crime
Science
FDA Advisory Committees Support Expanded Use of CAR-T Therapies from Bristol Myers Squibb and Johnson & Johnson Despite Safety Concerns
Authors
16
4 months
Bio
Science
FDA Concerns: CAR-T Cell Therapy Shows Promise in Shrinking Aggressive Brain Tumors with Johnson & Johnson and Bristol Myers Squibb
Authors
22
4 months
Bio
Science
Bristol Myers Squibb Gathers $85 Billion for Acquisitions Bond Sale, Prices $13 Billion in Notes
Authors
5
5 months
Economics
Business
Senate Committee Hearing: Senators Grill Merck, J&J, and Bristol Myers Squibb CEOs Over Exorbitant U.S. Drug Prices
Authors
28
5 months
Bio
Science
Senate Grills Merck, J&J, Bristol Myers CEOs on U.S. Drug Prices, No Price Cuts Pledged
Authors
19
5 months
Economics
Business
LIVE NOW: Senate Hearing with Pharma CEOs from Johnson & Johnson, Merck, Bristol Myers Squibb on High Drug Prices
Authors
5
5 months
Bio
Science
Sanders Report: Keytruda's US Price Hike, Welch's Panel on Big Pharma's Practices
Authors
11
5 months
Politics
Cell Therapy Research, Including CAR-T for Lupus, Gains Momentum at New York University and Rocket Pharmaceuticals, Nature Medicine Reports Secondary T Cell Lymphoma and Hereditary Swelling Disorder Potential
Authors
11
5 months
Bio
Science
COUR Pharmaceuticals Secures $105M Series A on Tuesday for Autoimmune R&D
Authors
5
5 months
Bio
Science
BMS's $4.1 Billion Tender Offer for RayzeBio to Expire on February 22
Authors
6
5 months
Bio
Science
Bristol Myers Squibb Wins $14 Billion Bid for Karuna Therapeutics in Neuro Deals
Authors
6
5 months
Bio
Science
BMS Acquires RayzeBio for $4.1B, Expanding into Radiopharma Market
Authors
5
6 months
AI
Tech
Bristol Myers' Second Major Buy: Acquires RayzeBio for $4.1B Amid Stock Surge
Authors
9
6 months
Economics
Business
Sanders Pressures Merck, J&J, Bristol Myers Squibb on Drug Pricing; UnitedHealthcare Accused of Care Restrictions
Authors
4
7 months
Economics
Business
Previous
Next